✦ LIBER ✦

Association ofVKORC1andCYP2C9polymorphisms with warfarin dose requirements in Japanese patients

✍ Scribed by Taisei Mushiroda; Yozo Ohnishi; Susumu Saito; Atsushi Takahashi; Yuka Kikuchi; Shigeru Saito; Hideki Shimomura; Yasuhiko Wanibuchi; Takao Suzuki; Naoyuki Kamatani; Yusuke Nakamura

Book ID: 106251989
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 209 KB
Volume: 51
Category: Article
ISSN: 1435-232X
DOI: 10.1007/s10038-005-0354-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VKORC1andCYP2C9polymorphisms are associa

VKORC1andCYP2C9polymorphisms are associated with warfarin dose requirements in Turkish patients

✍ G. Oner Ozgon; T. Y. Langaee; H. Feng; N. Buyru; T. Ulutin; A. C. Hatemi; A. Siv 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 134 KB

Evaluation of the effects ofVKORC1polymo

Evaluation of the effects ofVKORC1polymorphisms and haplotypes,CYP2C9genotypes, and clinical factors on warfarin response in Sudanese patients

✍ Nassr Eldin M. A. Shrif; Hong-Hee Won; Seung-Tae Lee; Jun-Hee Park; Ka-Kyung Kim 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 266 KB

Combination of Phenotype Assessments and

Combination of Phenotype Assessments and CYP2C9-VKORC1 Polymorphisms in the Determination of Warfarin Dose Requirements in Heavily Medicated Patients

✍ Michaud, V; Vanier, M-C; Brouillette, D; Roy, D; Verret, L; Noel, N; Taillon, I; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB

Association of polymorphisms in the cyto

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

✍ Guruprasad P Aithal; Christopher P Day; Patrick JL Kesteven; Ann K Daly 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 72 KB

The impact ofCYP2C9andVKORC1genetic poly

The impact ofCYP2C9andVKORC1genetic polymorphism and patient characteristics upon warfarin dose requirements in an adult Turkish population

✍ Nihat Ozer; Nese Cam; Burak Tangurek; Songul Ozer; Huseyin Uyarel; Dilaver Oz; M 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 251 KB

Low dose requirement for warfarin treatm

Low dose requirement for warfarin treatment in a patient with CYP2C9*3/*13 genotype

✍ Min-Jung Kwon; Young-Keun On; Wooseong Huh; Jae-Wook Ko; Duk-Kyung Kim; June Soo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 237 KB